Updated Jul 16, 2026 · Last SEC filing 2026-07-02
Beam Therapeutics Inc. (BEAM) has filed 10 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-02. 2 Form 8-K material event filings were reported by BEAM in the last 90 days. 2 Form 144 notices of proposed sale were filed for BEAM stock. InsiderAlpha tracks every BEAM SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Biological Products, (No Diagnostic Substances) (SIC 2836) |
|---|---|
| SEC CIK | 0001745999 |
| Form 4 filings (90d) | 10 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Form 144 notices (90d) | 2 |
| Latest Form 4 filing | 2026-07-02 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Evans John M. | CEO | M — Option exercise | 25.0K | $1.03 | $26K | SEC | |
| Simon Amy | Chief Medical Officer | S — Open-market sale | 373 | $34.73 | $13K | SEC | |
| Evans John M. | CEO | S — Open-market sale | 1.9K | $34.84 | $66K | SEC | |
| Evans John M. | CEO | S — Open-market sale | 23.1K | $34.26 | $791K | SEC | |
| Evans John M. | CEO | S — Open-market sale | 13.4K | $35.13 | $472K | SEC | |
| Evans John M. | CEO | S — Open-market sale | 11.6K | $35.91 | $416K | SEC | |
| Evans John M. | CEO | M — Option exercise | 6.3K | $1.03 | $7K | SEC | |
| Evans John M. | CEO | M — Option exercise | 18.7K | $0.67 | $13K | SEC | |
| FMR LLC | Insider | S — Open-market sale | 251.5K | $35.26 | $8.87M | SEC | |
| FMR LLC | Insider | S — Open-market sale | 33.4K | $35.12 | $1.17M | SEC | |
| Ciaramella Giuseppe | President | M — Option exercise | 29.0K | $1.03 | $30K | SEC | |
| Ciaramella Giuseppe | President | M — Option exercise | 6.5K | $0.67 | $4K | SEC | |
| Simon Amy | Chief Medical Officer | S — Open-market sale [10b5-1] | 6.7K | $24.58 | $165K | SEC | |
| Cavanagh Bethany J | SVP, Finance and Treasurer | S — Open-market sale [10b5-1] | 3.2K | $24.58 | $80K | SEC | |
| Bellon Christine | Chief Legal Officer | S — Open-market sale [10b5-1] | 6.0K | $24.58 | $146K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Beam Therapeutics Inc. (BEAM). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Evans John M. | 10 | $1.79M |
| Ciaramella Giuseppe | 4 | $34K |
| FMR LLC | 2 | $10.04M |
| Simon Amy | 1 | $13K |
| MARAGANORE JOHN | 1 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in BEAM insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live BEAM dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.